Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoki Naoe

Showing results (261-270 of 288) with videos related to

Pageof 29
Sort By:
Blood|November 3, 2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetHartmut Döhner, Elihu H Estey, Sergio Amadori, et al.
International Journal of Hematology|March 6, 2009
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemiaHisashi Sakamaki, Ken-Ichi Ishizawa, Masafumi Taniwaki, et al.
Blood|February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.
Leukemia Research|May 1, 2010
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraDong-Wook Kim, Shripad D Banavali, Udomsak Bunworasate, et al.
Blood|December 31, 2010
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 StudyShuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa, et al.
International Journal of Hematology|November 2, 2015
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral bloodKunio Kitamura, Takahiro Nishiyama, Ken Ishiyama, et al.
Annals of Hematology|September 26, 2018
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 studyNaomi Kawashima, Akimi Akashi, Yasunobu Nagata, et al.
Blood|August 10, 2010
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 StudyShigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita, et al.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Leukemia|August 11, 2018
Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 studyAkihiro Takeshita, Norio Asou, Yoshiko Atsuta, et al.
Pageof 29

Showing results (261-270 of 288) with videos related to

Sort By:
Pageof 29
Blood|November 3, 2009
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetHartmut Döhner, Elihu H Estey, Sergio Amadori, et al.
International Journal of Hematology|March 6, 2009
Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemiaHisashi Sakamaki, Ken-Ichi Ishizawa, Masafumi Taniwaki, et al.
Blood|February 27, 2019
Management of acute promyelocytic leukemia: updated recommendations from an expert panel of the European LeukemiaNetMiguel A Sanz, Pierre Fenaux, Martin S Tallman, et al.
Leukemia Research|May 1, 2010
Chronic myeloid leukemia in the Asia-Pacific region: current practice, challenges and opportunities in the targeted therapy eraDong-Wook Kim, Shripad D Banavali, Udomsak Bunworasate, et al.
Blood|December 31, 2010
A randomized comparison of 4 courses of standard-dose multiagent chemotherapy versus 3 courses of high-dose cytarabine alone in postremission therapy for acute myeloid leukemia in adults: the JALSG AML201 StudyShuichi Miyawaki, Shigeki Ohtake, Shin Fujisawa, et al.
International Journal of Hematology|November 2, 2015
Clinical usefulness of WT1 mRNA expression in bone marrow detected by a new WT1 mRNA assay kit for monitoring acute myeloid leukemia: a comparison with expression of WT1 mRNA in peripheral bloodKunio Kitamura, Takahiro Nishiyama, Ken Ishiyama, et al.
Annals of Hematology|September 26, 2018
Clinical significance of ASXL2 and ZBTB7A mutations and C-terminally truncated RUNX1-RUNX1T1 expression in AML patients with t(8;21) enrolled in the JALSG AML201 studyNaomi Kawashima, Akimi Akashi, Yasunobu Nagata, et al.
Blood|August 10, 2010
Randomized study of induction therapy comparing standard-dose idarubicin with high-dose daunorubicin in adult patients with previously untreated acute myeloid leukemia: the JALSG AML201 StudyShigeki Ohtake, Shuichi Miyawaki, Hiroyuki Fujita, et al.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Leukemia|August 11, 2018
Tamibarotene maintenance improved relapse-free survival of acute promyelocytic leukemia: a final result of prospective, randomized, JALSG-APL204 studyAkihiro Takeshita, Norio Asou, Yoshiko Atsuta, et al.
Pageof 29